We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Fought Labeling Changes for Olanzapine Safety in 2009
Eli Lilly Fought Labeling Changes for Olanzapine Safety in 2009
July 27, 2011
Even though a draft guidance on the topic just came out in April, the FDA has been regulating drugmakers under the FD&C Act’s section 505(o)(4) since the FDA Amendments Act was passed in September 2007.